Publications by authors named "Maria D Cappellini"

Claim this Profile
F
From Science to Solidarity: A Two-Decade Collaboration in Thalassemia.
Ali T Taher, Maria Domenica Cappellini

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study.
Ali T Taher, Vip Viprakasit, Antonis Kattamis, Silverio Perrotta, Paolo Ricchi, Maria Domenica Cappellini

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalassemia and hypercoagulability.
Maria Domenica Cappellini, Ali T Taher, Irene Motta

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of splanchnic venous thrombosis after splenectomy in hematologic diseases. systematic review, meta-analysis and consensus guidelines.
Núria Lluís, Filipe Kunzler, Levan Tsamalaidze, Domenech Asbun, Agustín Manresa-Rocamora, Maria Domenica Cappellini

Int J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trial.
Khaled M Musallam, Ali T Taher, John B Porter, Antonis Kattamis, Mrudula B Glassberg, Maria Domenica Cappellini

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.
Raffaella Origa, Barbara Gianesin, Antonietta Zappu, Anna Rita Denotti, Mary Ann Di Giorgio, Maria Domenica Cappellini

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial.
Ali T Taher, Hanny Al-Samkari, Yesim Aydinok, Martin Besser, Audra N Boscoe, Maria Domenica Cappellini

Lancet· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron Chelation Therapy.
Maria Domenica Cappellini, Natalia Scaramellini, Simona Leoni, Irene Motta

Adv Exp Med Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept versus mitapivat for non-transfusion-dependent β-thalassemia: Dare to compare?
Khaled M Musallam, Sujit Sheth, Maria Domenica Cappellini, Kevin H M Kuo, Antonis Kattamis

Hemasphere· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy for sickle cell disease and thalassemia.
Natalia Scaramellini, Daniele Lello Panzieri, Maria Domenica Cappellini

Curr Opin Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Transfusion-Dependent Thalassemia: An Image Gallery Worth a Thousand Words.
Khaled M Musallam, Sujit Sheth, Thomas D Coates, Hanny Al-Samkari, Maria Domenica Cappellini

Am J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial.
Maria Domenica Cappellini, Vip Viprakasit, Pencho Georgiev, Thomas D Coates, Raffaella Origa

Lancet Haematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIF Guidelines for the Management of Transfusion-Dependent β-Thalassemia.
Khaled M Musallam, Maria Domenica Cappellini, John B Porter, Dimitrios Farmakis, Androulla Eleftheriou

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypercoagulability in hemoglobinopathies: Decoding the thrombotic threat.
Rayan Bou-Fakhredin, Maria Domenica Cappellini, Ali T Taher, Lucia De Franceschi

Am J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia.
Daniele Lello Panzieri, Dario Consonni, Natalia Scaramellini, Guido Ausenda, Francesca Granata, Maria Domenica Cappellini

Am J Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease.
Irene Motta, Paola Delbini, Natalia Scaramellini, Viola Ghiandai, Lorena Duca, Maria Domenica Cappellini

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia: a retrospective medical record abstraction study.
Maria Domenica Cappellini, Mrudula B Glassberg, Juliana Meyers, Maria Jimenez, Tram Nham

Ther Adv Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A glutamine metabolic switch supports erythropoiesis.
Junhua Lyu, Zhimin Gu, Yuannyu Zhang, Hieu S Vu, Christophe Lechauve, Maria Domenica Cappellini

Science· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trial.
Ali T Taher, Khaled M Musallam, Vip Viprakasit, Antonis Kattamis, Jennifer Lord-Bessen, Maria Domenica Cappellini

BMJ Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease in Hemoglobin Levels during Acute Attacks in Patients with Idiopathic Recurrent Pericarditis: A Model of Anemia in Acute Disease.
Francesca Casarin, Ruggiero Mascolo, Irene Motta, Maddalena Alessandra Wu, Emanuele Bizzi, Maria Domenica Cappellini

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia.
Khaled M Musallam, Sujit Sheth, Maria Domenica Cappellini, Gian Luca Forni, Aurelio Maggio

Expert Rev Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Gene Editing for Hemoglobinopathies.
Ugo Testa, Giuseppe Leone, Maria Domenica Cappellini

Mediterr J Hematol Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia.
Achille Iolascon, Immacolata Andolfo, Roberta Russo, Mayka Sanchez, Fabiana Busti, Maria Domenica Cappellini

Hemasphere· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Step out of the shadows: a call for action for rare diseases.
Francesca Granata, Rayan Bou-Fakhredin, Maria Domenica Cappellini, Irene Motta

Lancet Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis